Home > Products > Active Pharmaceutical Ingredient

Active Pharmaceutical Ingredient

You can also try the following methods, and our professionals will serve you Customized Consultation
Cat. No. Product Name Field of Application Chemical Structure
DCAPI1267 Dipyridamole (Persantine) Dipyridamole (Persantine)
DCAPI1398 Disulfiram (Antabuse) Featured Disulfiram (Antabuse)
DCAPI1335 Divalproex sodium Divalproex sodium
DCAPI1183 DL-Carnitine HCl DL-Carnitine HCl
DCAPI1299 Docosanol (Abreva) Docosanol (Abreva)
DCAPI1022 Dofetilide (Tikosyn) Featured Dofetilide (Tikosyn)
DC9133 Domperidone Domperidone is a dopamine blocker and an antidopaminergic reagent.
DC9102 Donepezil Donepezil(E 2020) is a specific and potent AChE inhibitor for bAChE and hAChE with IC50 of 8.12 nM and 11.6 nM, respectively.
DCAPI1164 Doripenem Hydrate Doripenem Hydrate
DC9061 Doxepin HCl Doxepin HCl is a tricyclic antidepressant that is marketed worldwide.
DCAPI1241 Doxercalciferol (Hectorol) Featured Doxercalciferol is a synthetic vitamin D2 analog, suppressing parathyroid synthesis and secretion, used to treat secondary hyperparathyroidism and metabolic bone disease.
DC8994 Doxifluridine/5-Fluoro-5′-deoxyuridine Doxifluridine(Ro 21-9738; 5'-DFUR) is a thymidine phosphorylase activator for PC9-DPE2 cells with IC50 of 0.62 μM.
DC9109 Doxylamine succinate Doxylamine is a first generation antihistamine; can be used by itself as a short-term sedative and in combination with other drugs to provide night-time allergy and cold relief.
DCAPI1457 Dronedarone Hydrochloride Dronedarone is a Class III antiarrhythmic and a multi-channel blocker for atrial fibrillation. It blocks potassium and sodium and is a calcium channel protein inhibitor.
DCAPI1441 Seocalcitol EB1089 is an analog of 1,25 dihydroxyvitamin D which acts as a vitamin D receptor (VDR). EB1089 is noted to reverse hypercalcemia and is a potent inhibitor of PTH-rP (parathyroid hormone-related peptide, PTHRP) in vitro. In studies utilizing a squamous ca
DCAPI1162 Ecdysone Ecdysone
DCAPI1408 Echinocandin B0 Echinocandin B0
DCAPI1126 Econazole nitrate (Spectazole) Econazole nitrate (Spectazole)
DCAPI1380 Edaravone (MCI-186) Edaravone (MCI-186)
DCAPI1479 Efavirenz Efavirenz is a nonnucleoside HIV-1 reverse transcriptase (RT) inhibitor which selectively inhibits the glucuronidation of 3'-Azido-3'-deoxythymidine β-D-glucuronide, Sodium Salt. Studies suggest that Efavirenz binds to a distinct site of reverse transcrip
DCAPI1410 Eldecalcitol Featured Eldecalcitol (ED-71; 2.beta.-(3-Hydroxypropoxy)-1.alpha.,25-dihydroxyvitamin D3) is an analog of 1,25-dihydroxyvitamin D3 that improves bone mineral density. Eldecalcitol (ED-71; 2.beta.-(3-Hydroxypropoxy)-1.alpha.,25-dihydroxyvitamin D3) is more efficaci
DCAPI1504 Elocalcitol Elocalcitol
DCAPI1196 Eltrombopag (SB-497115-GR) Featured Eltrombopag (SB-497115-GR)
DCAPI1334 Enalapril maleate (Vasotec) Enalapril maleate (Vasotec)
DCAPI1356 Epalrestat Featured Epalrestat is an orally active aldose reductase inhibitor that acts on diabetic neuropathy.
DCAPI1014 Eplerenone Featured Eplerenone, also known as Inspra and CGP-30083, is a selective aldosterone receptor antagonist used to treat hypertension and congestive heart failure. Eplerenone provides marked protection against vascular injury in the kidney and heart.
DC9171 Eprosartan mesylate Eprosartan is a nonpeptide angiotensin II receptor antagonist with IC50 of 9.2 and 3.9 nM in rat and human adrenal cortical membranes, respectively.
DCAPI1365 Erdosteine Erdosteine
DCAPI1539 Eribulin Mesylate Featured Eribulin is an anticancer drug marketed by Eisai Co. under the trade name Halaven. Eribulin is also known as E7389 and ER-086526, and also carries the US NCI designation NSC-707389. It is used to treat certain patients with breast cancer and liposarcoma.
DCAPI1516 Eribulin Eribulin Mesylate (E7389 Mesylate), a synthetic analogue of halichondrin B in phase III clinical trials for breast cancer, binds to tubulin and microtubules.

Customized Consultation X

Your information is safe with us. * Required Fields.

Your name
Company
Email
Procuct Name
Cat. No.
Remark
Verification code
Please fill out the characters in the picture
X
>